Regent Investment Management LLC reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,627 shares of the healthcare conglomerate’s stock after selling 55 shares during the quarter. UnitedHealth Group makes up 0.9% of Regent Investment Management LLC’s investment portfolio, making the stock its 28th largest position. Regent Investment Management LLC’s holdings in UnitedHealth Group were worth $3,582,000 as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in the stock. Accel Wealth Management bought a new position in shares of UnitedHealth Group during the fourth quarter worth about $26,000. Front Row Advisors LLC increased its holdings in shares of UnitedHealth Group by 288.0% during the 3rd quarter. Front Row Advisors LLC now owns 97 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 72 shares during the last quarter. Sage Private Wealth Group LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $36,000. IronBridge Private Wealth LLC acquired a new position in UnitedHealth Group in the 4th quarter worth about $37,000. Finally, Costello Asset Management INC boosted its position in shares of UnitedHealth Group by 500.0% during the 4th quarter. Costello Asset Management INC now owns 120 shares of the healthcare conglomerate’s stock valued at $42,000 after purchasing an additional 100 shares in the last quarter. Hedge funds and other institutional investors own 86.03% of the company’s stock.
In other UnitedHealth Group news, Director Richard T. Burke sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, February 11th. The shares were sold at an average price of $335.80, for a total transaction of $1,679,000.00. Following the completion of the transaction, the director now owns 153,953 shares in the company, valued at approximately $51,697,417.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Thomas E. Roos sold 619 shares of the stock in a transaction dated Tuesday, February 9th. The shares were sold at an average price of $323.90, for a total transaction of $200,494.10. Following the completion of the transaction, the chief accounting officer now owns 31,908 shares of the company’s stock, valued at approximately $10,335,001.20. The disclosure for this sale can be found here. Insiders have sold 15,119 shares of company stock valued at $5,440,869 in the last ninety days. Insiders own 0.80% of the company’s stock.
Shares of NYSE UNH traded down $2.00 on Thursday, reaching $396.81. 25,116 shares of the company traded hands, compared to its average volume of 3,381,252. UnitedHealth Group Incorporated has a fifty-two week low of $273.71 and a fifty-two week high of $401.48. The stock has a market capitalization of $375.11 billion, a PE ratio of 22.91, a P/E/G ratio of 1.55 and a beta of 0.74. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.59. The company has a 50 day moving average of $366.08 and a 200 day moving average of $344.76.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Wednesday, April 14th. The healthcare conglomerate reported $5.31 EPS for the quarter, beating analysts’ consensus estimates of $4.38 by $0.93. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The business had revenue of $70.20 billion during the quarter, compared to the consensus estimate of $69.13 billion. During the same quarter in the prior year, the company posted $3.72 earnings per share. The firm’s revenue was up 9.0% on a year-over-year basis. As a group, research analysts expect that UnitedHealth Group Incorporated will post 16.75 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 23rd. Investors of record on Monday, March 15th were paid a $1.25 dividend. The ex-dividend date of this dividend was Friday, March 12th. This represents a $5.00 dividend on an annualized basis and a yield of 1.26%. UnitedHealth Group’s dividend payout ratio is presently 33.09%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.
Featured Article: How do CD ladders protect against rising interest rates?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.